| NM_130786 |
A1BG |
Alpha-1-B glycoprotein |
4.645 |
0.026 |
0.032 |
Plasma glycoprotein |
| NM_001023587 |
ABCC5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
1.069 |
0.037 |
0.041 |
Drug efflux transporter |
| NM_001615 |
ACTG2 |
Actin, gamma 2, smooth muscle, enteric |
6.495 |
0.001 |
0.002 |
Cell motility |
| NM_001633 |
AMBP |
Alpha-1-microglobulin/bikunin precursor |
1.531 |
0.000 |
0.000 |
Precursor of urinary trypsin inhibitor and lipocalin transport protein |
| NM_001643 |
APOA2 |
Apolipoprotein A2 |
2.434 |
0.000 |
0.000 |
Stabilize high density lipoprotein (HDL) structure and HDL metabolism |
| NM_000041 |
APOE |
Apolipoprotein E |
2.519 |
0.002 |
0.004 |
Lipoprotein catabolism, binding and internalization |
| NM_001645 |
APOC1 |
Apolipoprotein C1 |
1.601 |
0.000 |
0.000 |
Modulate lipoprotein interactions |
| NM_152547 |
BTNL9 |
Butyrophilin-like protein 9 precursor |
1.693 |
0.000 |
0.000 |
Membrane-based protein with unknown function |
| NM_001855 |
COL15A1 |
Collagen, type XV, alpha 1 |
2.858 |
0.013 |
0.019 |
Structural protein |
| NM_001008540 |
CXCR4 |
Chemokine (C-X-C motif) receptor 4 |
2.663 |
0.000 |
0.000 |
Receptor specific for stromal cell-derived factor-1 |
| NM_001135604 |
ESM1 |
Endothelial cell-specific molecule 1 |
2.590 |
0.018 |
0.024 |
Lung endothelial cell-leukocyte interactions and endothelium-dependent pathological disorders |
| NM_001442 |
FABP4 |
Fatty acid binding protein 4, adipocyte |
2.183 |
0.000 |
0.000 |
Fatty acid uptake, transport, and metabolism |
| NM_004467 |
FGL1 |
Fibrinogen-like 1 |
2.832 |
0.000 |
0.000 |
Hepatocyte mitogenic activity, HCC development |
| NM_004484 |
GPC3 |
Glypican 3 |
2.686 |
0.026 |
0.032 |
Control of cell division and growth regulation |
| NR_002196 |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
2.900 |
0.000 |
0.000 |
Tumor suppression |
| NM_000412 |
HRG |
Histidine-rich glycoprotein |
1.713 |
0.031 |
0.036 |
Blood coagulation |
| NM_000599 |
IGFBP5 |
Insulin-like growth factor binding protein 5 |
2.992 |
0.000 |
0.000 |
Prolong the half-life of the IGFs and regulate the growth promoting effects of IGFs |
| NM_002215 |
ITIH1 |
Inter-alpha (globulin) inhibitor H1 |
2.536 |
0.018 |
0.024 |
Hyaluronan synthesis, binding and transport and stimulation of phagocytotic cells |
| NM_002217 |
ITIH3 |
Inter-alpha (globulin) inhibitor H3 |
4.975 |
0.013 |
0.019 |
Extracellular matrix stabilization |
| NM_002291 |
LAMB1 |
Laminin, beta 1 |
1.633 |
0.037 |
0.041 |
Cell adhesion, differentiation and migration |
| NM_005947 |
MT1B |
Metallothionein 1B |
6.818 |
0.000 |
0.000 |
Bind heavy metals |
| NM_000607 |
ORM1 |
Orosomucoid 1 |
2.699 |
0.000 |
0.000 |
Unknown but suspected to be linked to immunosuppression |
| NM_001145031 |
PLAU |
Plasminogen activator, urokinase |
2.348 |
0.032 |
0.037 |
Degradation of the extracellular matrix |
| NM_006622 |
PLK2 |
Polo-like kinase 2 |
2.320 |
0.000 |
0.000 |
Regulation cell cycle progression, mitosis, cytokinesis, and DNA damage response |
| NM_031310 |
PLVAP |
Plasmalemma vesicle associated protein |
1.804 |
0.000 |
0.000 |
Formation of stomatal, microvascular permeability and fenestral diaphragms |
| NM_015869 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
2.501 |
0.010 |
0.015 |
Regulation of adipocyte differentiation |
| NM_012212 |
PTGR1 |
Prostaglandin reductase 1 |
1.629 |
0.023 |
0.029 |
Inactivation of the chemotactic factor, leukotriene B4 |
| NM_021033 |
RAP2A |
RAP2A, member of RAS oncogene family |
2.110 |
0.031 |
0.036 |
GTPase activity |
| NM_001085 |
SERPINA3 |
Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
1.509 |
0.031 |
0.036 |
Plasma protease inhibitor |
| NM_012339 |
TSPAN15 |
Tetraspanin 15 |
4.210 |
0.000 |
0.000 |
Regulation of cell development, activation, growth and motility |
